MILESTONE SCIENTIFIC INC. (MLSS) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
32/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseMLSS / S&P 10.34% / 15.20% |
LoseMLSS / S&P 3.72% / 15.00% |
LoseMLSS / S&P -55.56% / 50.40% |
| 2026-Q11/3 |
WinMLSS / S&P 7.41% / -4.33% |
LoseMLSS / S&P 3.37% / 11.30% |
LoseMLSS / S&P MLSS unavailable / 27.70% |
| 2025-Q40/3 |
LoseMLSS / S&P -40.00% / 2.65% |
LoseMLSS / S&P 3.99% / 9.00% |
LoseMLSS / S&P MLSS unavailable / 13.40% |
| 2025-Q30/3 |
LoseMLSS / S&P -29.69% / 8.12% |
LoseMLSS / S&P 0.59% / 4.61% |
LoseMLSS / S&P MLSS unavailable / 13.45% |
| 2025-Q21/3 |
LoseMLSS / S&P -31.18% / 10.94% |
WinMLSS / S&P 7.84% / 4.83% |
LoseMLSS / S&P MLSS unavailable / 10.63% |
| 2025-Q11/3 |
WinMLSS / S&P -3.12% / -4.27% |
LoseMLSS / S&P -9.13% / 4.98% |
LoseMLSS / S&P MLSS unavailable / 10.57% |
| 2024-Q41/3 |
WinMLSS / S&P 5.49% / 2.41% |
LoseMLSS / S&P -12.19% / 5.25% |
LoseMLSS / S&P MLSS unavailable / 6.15% |
| 2024-Q31/3 |
WinMLSS / S&P 33.82% / 5.89% |
LoseMLSS / S&P -9.49% / 5.89% |
LoseMLSS / S&P MLSS unavailable / 6.11% |
| 2024-Q21/3 |
WinMLSS / S&P 9.68% / 4.28% |
LoseMLSS / S&P -15.47% / 5.38% |
LoseMLSS / S&P MLSS unavailable / 5.12% |
| 2024-Q11/3 |
LoseMLSS / S&P -10.14% / 10.56% |
WinMLSS / S&P 8.92% / 5.71% |
LoseMLSS / S&P MLSS unavailable / 5.59% |
| 2023-Q41/3 |
LoseMLSS / S&P -25.00% / 11.69% |
WinMLSS / S&P 11.60% / 6.81% |
LoseMLSS / S&P MLSS unavailable / 7.78% |
| 2023-Q31/3 |
WinMLSS / S&P 5.75% / -3.27% |
LoseMLSS / S&P 4.22% / 7.52% |
LoseMLSS / S&P MLSS unavailable / -5.03% |
| 2023-Q20/3 |
LoseMLSS / S&P -3.33% / 8.74% |
LoseMLSS / S&P 7.10% / 9.50% |
LoseMLSS / S&P MLSS unavailable / -8.57% |
| 2023-Q11/3 |
WinMLSS / S&P 87.50% / 7.50% |
LoseMLSS / S&P -13.67% / 10.77% |
LoseMLSS / S&P MLSS unavailable / -15.69% |
| 2022-Q40/3 |
LoseMLSS / S&P -39.24% / 7.56% |
LoseMLSS / S&P -14.54% / 11.88% |
LoseMLSS / S&P MLSS unavailable / -17.99% |
| 2022-Q31/3 |
LoseMLSS / S&P -14.13% / -4.88% |
LoseMLSS / S&P -2.69% / 13.47% |
WinMLSS / S&P 33.33% / -1.41% |
| 2022-Q21/3 |
LoseMLSS / S&P -39.47% / -16.10% |
LoseMLSS / S&P 5.62% / 13.71% |
WinMLSS / S&P 50.00% / 11.04% |
| 2022-Q11/3 |
LoseMLSS / S&P -26.21% / -4.60% |
WinMLSS / S&P 53.89% / 15.97% |
LoseMLSS / S&P 20.00% / 42.23% |
| 2021-Q41/3 |
LoseMLSS / S&P 10.16% / 11.03% |
WinMLSS / S&P 89.52% / 15.00% |
LoseMLSS / S&P -16.67% / 96.40% |
| 2021-Q31/3 |
LoseMLSS / S&P -23.67% / 0.58% |
WinMLSS / S&P 75.00% / 10.77% |
LoseMLSS / S&P -43.75% / 69.42% |
| 2021-Q21/3 |
LoseMLSS / S&P -31.37% / 8.55% |
WinMLSS / S&P 42.54% / 6.58% |
LoseMLSS / S&P -60.00% / 51.81% |
| 2021-Q11/3 |
WinMLSS / S&P 68.40% / 6.17% |
LoseMLSS / S&P -20.79% / -1.06% |
LoseMLSS / S&P -37.50% / 7.39% |
| 2020-Q42/3 |
WinMLSS / S&P 52.52% / 12.15% |
LoseMLSS / S&P -35.07% / -3.72% |
WinMLSS / S&P -20.00% / -33.42% |
| 2020-Q31/3 |
LoseMLSS / S&P -28.72% / 8.93% |
LoseMLSS / S&P -43.84% / -2.04% |
WinMLSS / S&P 77.78% / -27.10% |
| 2020-Q22/3 |
WinMLSS / S&P 56.00% / 20.54% |
LoseMLSS / S&P -35.37% / -0.46% |
WinMLSS / S&P 33.33% / -27.11% |
| 2020-Q12/3 |
WinMLSS / S&P -10.07% / -19.60% |
LoseMLSS / S&P -15.03% / 3.47% |
WinMLSS / S&P -5.88% / -14.75% |
| 2019-Q41/3 |
WinMLSS / S&P 67.47% / 9.07% |
LoseMLSS / S&P -12.97% / 5.36% |
LoseMLSS / S&P -28.57% / 2.99% |
| 2019-Q32/3 |
WinMLSS / S&P 130.56% / 1.70% |
WinMLSS / S&P 21.90% / 5.02% |
LoseMLSS / S&P -67.86% / 0.21% |
| 2019-Q21/3 |
WinMLSS / S&P 9.09% / 4.30% |
LoseMLSS / S&P 2.78% / 6.64% |
LoseMLSS / S&P -25.00% / 8.65% |
| 2019-Q10/3 |
LoseMLSS / S&P 0.00% / 13.65% |
LoseMLSS / S&P 3.55% / 8.12% |
LoseMLSS / S&P -19.05% / 14.29% |
| 2018-Q41/3 |
LoseMLSS / S&P -55.41% / -13.52% |
LoseMLSS / S&P -14.71% / 9.05% |
WinMLSS / S&P 23.53% / 18.23% |
| 2018-Q31/3 |
LoseMLSS / S&P -6.33% / 7.71% |
LoseMLSS / S&P MLSS unavailable / 10.21% |
WinMLSS / S&P 64.71% / 19.06% |
| 2018-Q21/3 |
WinMLSS / S&P 9.72% / 3.43% |
LoseMLSS / S&P MLSS unavailable / 9.03% |
LoseMLSS / S&P 5.26% / 14.46% |
| 2018-Q10/3 |
LoseMLSS / S&P -38.98% / -0.76% |
LoseMLSS / S&P MLSS unavailable / 7.68% |
LoseMLSS / S&P 5.00% / 12.46% |
| 2017-Q40/3 |
LoseMLSS / S&P -5.60% / 6.64% |
LoseMLSS / S&P MLSS unavailable / 7.03% |
LoseMLSS / S&P -19.05% / 13.82% |
| 2017-Q30/3 |
LoseMLSS / S&P -16.67% / 4.48% |
LoseMLSS / S&P MLSS unavailable / 5.68% |
LoseMLSS / S&P -22.73% / 17.57% |
| 2017-Q21/3 |
WinMLSS / S&P 11.11% / 3.09% |
LoseMLSS / S&P MLSS unavailable / 4.83% |
LoseMLSS / S&P -17.39% / 17.74% |
| 2017-Q10/3 |
LoseMLSS / S&P -3.57% / 6.07% |
LoseMLSS / S&P MLSS unavailable / 3.67% |
LoseMLSS / S&P -23.08% / 13.32% |
| 2016-Q40/3 |
LoseMLSS / S&P -35.19% / 3.82% |
LoseMLSS / S&P MLSS unavailable / 2.09% |
LoseMLSS / S&P -16.00% / 7.05% |
| 2016-Q30/3 |
LoseMLSS / S&P -22.86% / 3.85% |
LoseMLSS / S&P MLSS unavailable / 0.20% |
LoseMLSS / S&P -15.38% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MLSS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -13.56% | 20.78% |
| Annualized return | -13.56% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MLSS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -72.87% | 83.14% |
| Annualized return | -22.97% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | MLSS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -78.30% | 319.30% |
| Annualized return | -14.17% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |